Edition:
United Kingdom

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

7.65USD
18 Jan 2019
Change (% chg)

$-0.16 (-2.05%)
Prev Close
$7.81
Open
$7.89
Day's High
$7.89
Day's Low
$7.57
Volume
28,110
Avg. Vol
46,833
52-wk High
$15.90
52-wk Low
$2.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.628
Jun '18 0.00 -0.454
Mar '18 0.00 -0.268
FY 2017 Dec '17 0.02 -0.448
Sep '17 0.26 -0.430
Jun '17 0.01 -0.410
Mar '17 0.02 -0.419
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 0.00 0.00 0.00 4.00
Earnings (per share)
Year Ending Dec-19 3 -1.87 -1.67 -2.01 -1.73
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. 21.51 148.01 49.93
P/E Low - Last 5 Yrs. 21.51 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) 65.85 49.51 6.28
Price to Book (MRQ) 1.07 10.16 5.27
Price to Tangible Book (MRQ) 1.07 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 63.38 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.37 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -90.39 47.85 5.87
Sales - 5 Yr. Growth Rate -23.58 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 1.79 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -40.79 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -0.77 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 13.95 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -9.68 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -3,415.37 -- --
EBITD - 5 Yr. Avg -14.16 -110.23 12.87
Operating Margin (TTM) -3,496.71 -184.42 6.20
Operating Margin - 5 Yr. Avg. -18.89 -126.67 8.31
Pre-Tax Margin (TTM) -3,489.63 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -20.59 -132.83 8.61
Net Profit Margin (TTM) -3,489.63 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -20.59 -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 9,318 7,650,695 844,239,566
Net Income/Employee (TTM) -325,170 652,572 100,064,145
Receivable Turnover (TTM) 1.92 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.01 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.07 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -55.45 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -55.50 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -88.43 -59.61 -23.58
EPS (TTM) % -34.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xenon Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.64 -5.03 34 99
13 Week -9.09 -13.52 34 95
26 Week -22.08 -28.00 29 98
52 Week -63.64 -69.18 11 72
YTD -61.04 -65.78 7 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 71.83%
# of Holders: 67
Total Shares Held: 18,130,898
3 Mo. Net Change: 370,057
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 1
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.